1. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995;332:133-8.

2. Martinez FD. The connection between early life wheezing and subsequent asthma: the viral march. Allergol Immunopathol (Madr). 2009;37:249-51.

3. Aguirre V, Mallol J. Fisiologia do sistema respiratório na infância. In: Solé D, Wandalsen GF, Lanza FC, eds. Asma no lactente, na criança e no adolescente. 1ª ed. Rio de Janeiro: Atheneu; 2016. p. 13-16.

4. Ribeiro JD. Semiologia do sistema respiratório em crianças. In: Solé D, Wandalsen GF, Lanza FC, eds. Asma no lactente, na criança e no adolescente. 1ª ed. Rio de Janeiro: Atheneu, 2016. p. 17-28.

5. Global Initiative for Asthma – GINA- update 2018. Disponível em www.ginasthma.org . Acesso em janeiro de 2018.

6. Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Götz M, et al. Diagnosis and treatment of asthma in childhood: PRACTALL consensus report. Allergy. 2008;63(1):5-34.

7. Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, et al. International consensus on (ICON) pediatric asthma. Allergy. 2012;67(8):976-97.

8. Pisi G, Fainardi V, Aiello M, Bertorelli G, Crisafulli E, Chetta A. The role of the microbiome in childhood asthma. Immunotherapy. 2017;9(15):1295-304.

9. Lynch SV. The Lung Microbiome and Airway Disease. Ann Am Thorac Soc. 2016;13(5):S462‑S465.

10. Teo SM, Mok D, Pham K, Kusel M, Serralha M, Troy N, et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory inifection and risk of asthma development. Cell Host Microbe. 2015;17(5):704-15.

11. Rivas MN, Crother TR, Arditi M. The Microbiome in Asthma. Curr Opin Pediatr. 2016;28(6):764-71.

12. Sullivan A, Hunt E, MacSharry J, Murphy DM. The Microbiome and the Pathophysiology of Asthma. Resp Res. 2016;17:163.

13. Lemanske RF Jr, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005;116:571-7.

14. Rosenthal LA, Avila PC, Heymann PW, Martin RJ, Miller EK, Papadopoulos NG, et al. Viral respiratory tract infections and asthma: the course ahead. J Allergy Clin Immunol. 2010;125:1212-7.

15. Thomas AO, Lemanske RF Jr., Jackson DJ. Infections and their role in childhood asthma inception. Pediatr Allergy Immunol. 2014;25(2):122-8.

16. Kim CK, Callaway Z, Gern JE. Viral infections and associated factors that promote acute exacerbations of asthma. Allergy Asthma Immunol Res. 2018;10(1):12-7.

17. Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med. 2002;96:S1-S7.

18. Ducoffre G, Cauchi P, Hendrickx E. Respirarory syncytial virus epidemiology in Belgium in 1998, 1999 and 2000. J Perinat Med. 2001;29(Suppl I, Part 2):352.

19. Smyth RL, Openshaw PJM. Bronchiolitis. Lancet. 2006;368:312‑22.

20. Glezen WP, Paredes A, Allison JE, Taber KH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981;98:708-15.

21. Macanerney JM, Johnson S, Schoub BD. Surveillance of respiratory viruses: a 10-year laboratory-based study. S Afr Med J. 1994;84:473-7.

22. Hemming VG. Viral respiratory diseases in children: classification, etiology, epidemiology, and risk factors. J Pediatr.1994;124:S13‑S60.

23. Knott AM, Long CE, Hall CB. Parainfluenza viral infections in pediatrics outpatients: seasonal patterns and clinical characteristics. Pediatr Infect Dis J. 1994;13:269-73.

24. Woo PC, Lau SK, Chu CM. Characterization and complete genome sequence of a novel coronavirus HKU1 from patients with pneumonia. J Virol. 2005;79:884-95.

25. Foulongne V, Rodière M, Segondy M. Human Bocavirus in children. Emerg Infect Dis. 2006;12:1-4.

26. Manoha C, Espinosa S, Aho SL, Huet F, Pothier P. Epidemiological and clinical features of HMPV, RSV and RVs infections in young children. J Clin Virol. 2007;38:221-6.

27. Korppi M, Kotaniemi-Syrjanen A, Waris M, Vainionpaa R, Reijonen TM. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J. 2004;23(11):995-9.

28. Fuji N, Suzuki A, Lupisan S, Sombrero L, Galang H, Kamigaki T, et al. Detection of human rhinovirus C viral genome in blood among children with severe respiratory infections in the Philippines. PLoS One. 2011;6(11):e27247.

29. Lee WM, Lemanske RF Jr, Evans MD, Vang F, Pappas T, Gangnon R, et al. Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med. 2012;186(9):886‑91.

30. Cox DW, Bizzintino J, Ferrari G, Khoo SK, Zhang G, Whelan S, et al. Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions. Am J Respir Crit Care Med. 2013;188(11):1358‑64.

31. Monto AS. The seasonality of rhinovirus infections and its implications for clinical recognition. Clin Ther. 2002;24:1987-97.

32. Johnston NW, Johnston SL, Duncan JM, Greene JM, Kebadze T, Keith PK, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol. 2005;115:132-8.

33. Stern DA, Guerra S, Halonen M, Wright AL, Martinez FD. Low IFNgamma production in the first year of life as a predictor of wheeze during childhood. J Allergy Clin Immunol. 2007;120:835-41.

34. Kim JH, Kim YS, Cho GS, Kim NH, Gong CH, Lee BJ, et al. Human rhinovirus-induced proinflammatory cytokine and Interferon-β responses in nasal epithelial cells from chronic rhinosinusitis patients. Allergy Asthma Immunol Res. 2015;7:489-96.

35. Bochkov YA, Palmenberg AC, Lee WM, Rathe JA, Amineva SP, Sun X, et al. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat Med. 2011;17:627-32.

36. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med. 1995;151:879‑86.

37. Handzel ZT, Busse WW, Sedgwick JB, Vrtis R, Lee WM, Kelly EA, et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol. 1998;160:1279-84.

38. Chihara J, Urayama O, Tsuda A, Kakazu T, Higashimoto I, Yamada H. Eosinophil cationic protein induces insulin-like growth factor I receptor expression on bronchial epithelial cells. Int Arch Allergy Immunol. 1996;111(Suppl 1):43-5.

39. Papadopoulos NG, Gourgiotis D, Javadyan A, Bossios A, Kallergi K, Psarras S, et al. Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants? Respir Med. 2004;98:879-82.

40. Oliveira TF, Freitas GR, Ribeiro LZ, Yokosawa J, Siqueira MM, Portes SA, et al. Prevalence and clinical aspects of respiratory syncytial virus A and B groups in children seen at Hospital de Clínicas of Uberlândia, MG, Brazil. Mem Inst Oswaldo Cruz. 2008;103:417‑22.

41. Chong-Silva DC. Asma e Infecções virais: o ovo ou a galinha? J Paran Ped. 2009;10:14-16.

42. Liu AH, Covar RA, Spahn JD, Leung DY. Childhood asthma. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia (PA): Saunders Elsevier; 2007. p. 953-70.

43. Sims DG, Downham MA, Gardner PS. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. BMJ. 1978;1:11-7.

44. Sigurs N, Bjarnason R, Sigursbergsson F, Kjellman B, Brorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995;95:500-5.

45. Stein RT, Sherill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncycial virus in early life and risk of wheeze and allergy by age 13. Lancet. 1999;354: 541-5.

46. Ehlenfield DR, Cameron K, Welliver RC. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics. 2000;105:79-83.

47. Chong DC, Raboni SM, Abujamra K, Marani DM, Nogueira MB, Tsuchiya LR, et al. Respiratory virus in pediatric necropsies: an immunohistochemical study. Pediatr Develop Pathol. 2009;12:211-6.

48. Queiróz DA, Durigon EL, Botosso VF, Ejzemberg B, Vieira SE, Mineo JR, et al. Immune response to respiratory syncytial virus in young Brazilian children. Braz J Med Biol Res. 2002;35:1183-93.

49. Mohopatra SS, Lockey RF. Respiratory Syncytial Virus infection: from biology to therapy, a perspective. WAO Journal. 2008;1:21-8.

50. Welliver RC, Garofalo RP, Ogra PL. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J. 2002;21:457-61.

51. Noah TL, Becker S. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol. 2000;97:43-9.

52. Adams O, Weis J, Jasinska K, Vogel M, Tenenbaum T. Comparison of human metapneumovirus, respiratory syncytial virus and Rhinovirus respiratory tract infections in young children admitted to hospital. J Med Virol. 2015;87(2):275-8.

53. Matsuse H, Tsuchida T, Fukahori S, Kawano T, Tomari S, Matsuo N, et al. Differential airway inflammatory responses in asthma exacerbations induced by respiratory syncytial virus and influenza virus A. Int Arch Allergy Immunol. 2013;161:378-82.

54. Borish L, Rosenwasser LJ. Cytokines in allergic inflammation. In: Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FE, eds. Middleton’s allergy principles & practice. 6th ed. St. Louis (MO): Mosby; 2003. p. 35-57.

55. Welliver RC. Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection. Sem Perinatol. 1994;22:87-95.

56. Bont L, Van Aalderen WMC, Kimpen JLL. Long-term consequences of respiratory syncycial virus (RSV) bronchiolitis. Paediatr Respir Rev. 2000;1:221-7.

57. Openshaw PJ, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev. 2005;18:541-55.

58. Larrañaga C, Avendano L. Infección por virus sincicial respiratorio humano. Rev Chil Infectol. 1990;7:189-95.

59. Welliver RC, Duffy L. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol. 1993;15:19-27.

60. Caswell SJ, Thomson AH, Ashmore SP, Beardsmore CS, Simpson H. Lactent sensitization to respiratory syncytial virus during acute bronchiolitis and lung function after recovery. Arch Dis Child. 1990;65:946-52.

61. Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M. Differential immune response to acute lower respiratory illness in early life and subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol. 1998;102:915-20.

62. Sigurs N, Bjarnason R, Sigurbergsson F. Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy. Acta Paediatr. 1994;83:1151-5.

63. Singh AM, Moore PE, Gern JE, Lemanske RF Jr, Hartert TV. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. Am J Respir Crit Care Med. 2007;175(2):108-19.

64. Faber TE, Schuurhof A, Vonk A, Koppelman GH, Hennus MP, Kimpen JL, et al. IL1RL1 gene variants and nasopharyngeal IL1RL-a levels are associated with severe RSV bronchiolitis: a multicenter cohort study. PLoS One. 2012;7(5):e34364.

65. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med. 1988;319:1112-7.

66. Folkerts G, Nijkamp FP. Virus-induced airway hyperresponsiviness – role of inflammatory cells and mediators. Am J Respir Crit Care Med. 1995;151:1666-74.

67. Noma T, Mori A, Yoshizawa I. Induction of allergen-specific IL-2 responsiviness of lymphocytes after respiratory syncytial virus infection and prediction of onset of recurrent wheezing and bronchial asthma. J Allergy Clin Immunol. 1996;98:1-26.

68. Fonseca CB, Grisi S. Bronchiolitis, respiratory syncytial virus and recurrent wheezing: what is the relationship? Hosp Clin Fac Med S Paulo. 2003;58:39-48.

69. Meissner C, Storch GA. Picornaviruses: poliovirus, other enteroviruses, and the rhinoviruses. In: Schaechter M, Engleberg NC, Eisenstein BI, Medoff G, eds. Mechanisms of microbial disease. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 1999. p. 305‑14.

70. Smura T, Ylipaasto P, Klemola P, Kaijalainen S, Kyllönen L, Sordi V, et al. Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: implications for pathogenesis. J Med Virol. 2010;82:1940-9.

71. Foster CB, Friedman N, Carl J, Piedimonte G. Enterovirus D68: a clinically important respiratory enterovirus. Cleve Clin J Med. 2015;82:26-31.

72. Imamura T, Okamoto M, Nakakita S, Suzuki A, Saito M, Tamaki R, et al. Antigenic and receptor binding properties of enterovirus 68. J Virol. 2014;88:2374-84.

73. Glezen WP. Asthma, influenza, and vaccination. J Allergy Clin Immunol. 2006;118:1199‑206.

74. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283:499‑505.

75. Miller EK, Griffin MR, Edwards KM, Weinberg GA, Szilagyi PG, Staat MA, et al. Influenza burden for children with asthma. Pediatrics. 2008;121:1‑8.

76. Garcia-Garcia ML, Calvo C, Casas I, Bracamonte T, Rellan A, Gozalo F, et al. Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5. Pediatr Pulmonol. 2007;42:458‑64.

77. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bønnelykke K, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007;357(15):1487‑95.

78. De Schutter I, Dreesman A, Soetens O, De Waele M, Crokaert F, Verhaegen J, et al. In young children, persistent wheezing is associated with bronchial bacterial infection: a retrospective analysis. BMC Pediatr. 2012;12:83.

79. Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med. 1998;158:998‑1001.

80. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA. 1991;266(2):225‑30.

81. Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest. 2002;121(6):1782‑8.

82. Wood PR, Hill VL, Burks ML, Peters JI, Singh H, Kannan TR, et al. Mycoplasma pneumoniae in children with acute and refractory asthma. Ann Allergy Asthma Immunol. 2013;110(5):328‑34.

83. Belanger K, Beckett W, Triche E, Bracken MB, Holford T, McSharry J, et al. Symptoms of wheeze and persistent cough in the first year of life: associations with indoor allergens, air contaminants, and maternal history of asthma. Am J Epidemiol. 2003;158:195-202.

84. Chong Neto HJ, Rosário NA; Grupo EISL Curitiba (Estudio Internacional de Sibilancias en Lactantes). Risk factors for wheezing in the first year of life. J Pediatr (Rio J). 2008; 84(6):495-502.

85. Kulig M, Bergmann R, Tacke U, Wahn U, Guggenmoos-Holzmann I. Long-lasting sensitization to food during the first two years precedes allergic airway disease. The MAS Study Group, Germany. Pediatr Allergy Immunol. 1998;9:61‑7.

86. Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ. Atopic dermatitis and the atopic march revisited. Allergy. 2014;69(1):17‑27.

87. von Kobyletzki LB, Bornehag CG, Hasselgren M, Larsson M, Lindstrom CB, Svensson A. Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort. BMC Dermatol. 2012;12:11.

88. Warner JO; ETAC Study Group. Early Treatment of the Atopic Child. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months’ treatment and 18 months’ post treatment follow-up. J Allergy Clin Immunol. 2001;108(6):929‑37.

89. Filipiak-Pittroff B, Schnopp C, Berdel D, Naumann A, Sedlmeier S, Onken A, et al. Predictive value of food sensitization and filaggrin mutations in children with eczema. J Allergy Clin Immunol. 2011;128(6):1235‑41.

90. Zeiger RS, Heller S. The development and prediction of atopy in high-riskchildren: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol. 1995;95:1179‑90.

91. Lodge CJ, Lowe AJ, Gurrin LC, Hill DJ, Hosking CS, Khalafzai RU, et al. House dust mite sensitization in toddlers predicts current wheeze at age 12 years. J Allergy Clin Immunol. 2011;128:782‑8.

92. Sly PD, Boner AL, Bjorksten B, Bush A, Custovic A, Eigenmann PA, et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet. 2008;372:1100‑6.

93. Stoltz DJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Gern JE, et al. Specific patterns of allergic sensitization in early childhood and asthma & rhinitis risk. Clin Exp Allergy. 2013;43:233‑41.

94. Illi S, von Mutius E, Lau S, Niggemann B, Grüber C, Wahn U, et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet. 2006;368:763‑70.

95. Simpson A, Soderstrom L, Ahlstedt S, Murray CS, Woodcock A, Custovic A. IgE antibody quantification and the probability of wheeze in preschool children. J Allergy Clin Immunol. 2005;116:744‑9.

96. Lazic N, Roberts G, Custovic A, Belgrave D, Bishop CM, Winn J, et al. Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts. Allergy. 2013;68:764‑70.

97. Just J, Gouvis-Echraghi R, Rouve S, Wanin S, Moreau D, AnnesiMaesano I. Two novel, severe asthma phenotypes identified during childhood using a clustering approach. Eur Respir J. 2012;40:55‑60.

98. Garden FL, Simpson JM, Marks GB; CAPS Investigators. Atopy phenotypes in the Childhood Asthma Prevention Study (CAPS) cohort and the relationship with allergic disease: clinical mechanisms in allergic disease. Clin Exp Allergy. 2013;43:633‑41.

99. Belgrave DC, Buchan I, Bishop C, Lowe L, Simpson A, Custovic A. Trajectories of lung function during childhood. Am J Respir Crit Care Med. 2014;189:1101‑9.

100. Rubner FJ, Jackson DJ, Evans MD, et al. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol. 2017;139(2):501‑7.

101. Chang TS, Lemanske RF Jr, Guilbert TW, Gern JE, Coen MH, Evans MD, et al. Evaluation of the modified asthma predictive index in high-risk preschool children. J Allergy Clin Immunol Pract. 2013;1(2):152‑6.

102. Collins AS, Lockett GA, Holloway JW. The Genetics of Allergic Disease and Asthma. In: Leung DYM, Szefler SJ, Bonilla FA, Cezmi A Akdis CA, Sampson H, eds. Pediatric Allergy: Principles and Practice. 3rd Edition. Elsevier. p. 18-30.

103. Mallol J, García-Marcos L, Aguirre V, Martinez-Torres A, PerezFernández V, Gallardo A, et al. The international study of wheezing in infants: questionnaire validation. Int Arch Allergy Immunol. 2007;144:44-50.

104. Garcia-Marcos L, Mallol J, Solé D, Brand PL, EISL Study Group. International study of wheezing in infants: risk factors in affluent and non-affluent countries during the first year of life. Pediatr Allergy Immunol. 2010;21:878-88.

105. Mallol J, García-Marcos L, Solé D, Brand P; EISL Study Group. International prevalence of recurrent wheezing during the first year of life: variability, treatment patterns and use of health resources. Thorax. 2010;65:1004-9.

106. Mallol J, Solé D, Garcia-Marcos L, Rosário NA, Aguirre V, Chong HJ, et al. Prevalence, Severity, and Treatment of Recurrent Wheezing During the First Year of Life: A Cross-Sectional Study of 12,405 Latin American Infants. Allergy Asthma Immunol Res. 2016;8(1):22-31.

107. Fogaça HR, Marson FA, Toro AA, Solé D, Ribeiro JD. Epidemiological aspects of and risk factors for wheezing in the first year of life. J Bras Pneumol. 2014;40:617-25.

108. Chong Neto HJ, Rosario N, Solé D, Mallol J. Prevalência de sibilância recorrente em lactentes. J Pediatr (Rio J). 2007;83:357‑62.

109. Chong Neto HJ, Rosário N, Grassellis EA, Silvas FC, Bojarski L, Rosario CS, et al. Sibilância recorrente em lactentes: mudanças epidemiológicas. J Pediatr (Rio J). 2011;87:547-50.

110. Dela Bianca AC, Wandalsen GF, Mallol J, Sole D. Prevalence and severity of wheezing in the first year of life. J Bras Pneumol. 2010;36:402-9.

111. Aranda CS, Wandalsen GF, Fonzar LF, Dela Bianca ACC, Mallol J, Solé D. Risk factors for recurrent wheezing - International Study of Wheezing in Infants (EISL) Phase 3. Allergol immunopathol. 2016;44(1):3-8.

112. Aranda CS, Wandalsen GF, Dela Bianca AC, Moraes L, Lamenha Medeiros M, Mallol J, et al. Wheezing and the first thousand days of life. Pediatr Allergy Immunol. 2017;28(4):397-400.

113. International Study of Asthma and Allergies in Childhood Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351:1225-32.

114. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733-43.

115. Solé D, Wandalsen GF, Camelo-Nunes IC, Naspitz CK, ISAAC - Grupo Brasileiro. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC). Phase 3. J Pediatr (Rio J). 2006;82:341-6.

116. de Farias MR, Rosa AM, Hacon SS, de Castro HA, Ignotti E. Prevalence of asthma in schoolchildren in Alta Floresta- a municipality in the southeast of the Brazilian Amazon. Rev Bras Epidemiol. 2010;13:49-57.

117. Menin AMCR. Prevalência e gravidade dos sintomas de asma, rinite e eczema, em escolares de 6 a 7 anos, na cidade de São José do Rio Preto, SP, avaliados pelo ISAAC (International Study of Asthma and Allergies in Childhood) [tese de mestrado]. Ribeirão Preto (SP): USP, Faculdade de Medicina de Ribeirão Preto; 2008.

118. Castro LK, Cerci Neto A, Ferreira Filho OF. Prevalence of symptoms of asthma, rhinitis and atopic eczema among students between 6 and 7 years of age in the city of Londrina, Brazil. J Bras Pneumol. 2010;36:286-92.

119. Stelmach R, Neto AC, Fonseca AC, Ponte EV, Alves G, AraujoCosta IN, et al. A workshop on asthma management programs and centers in Brazil: reviewing and explaining concepts. J Bras Pneumol. 2015;41:3-15.

120. Prietsch SOM, Zhang L, Catharino AR, Vauchinski L, Rodrigues FE. Mortalidade por asma em crianças brasileiras de até 19 anos de idade no período entre 1980 a 2007. J Pediatr (Rio J). 2012;88(5):384-8.

121. Rackemann F. A working classification of asthma. Am J Med. 1947;3:601‑6.

122. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med. 1997;156:737‑43.

123. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716-25.

124. Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. Allergy Clin Immunol. 2011;127(2):355-60.

125. Canonica GW, Ferrando M, Baiardini I, Puggioni F, Racca F, Passalacqua G, et al. Asthma: personalized and precision medicine. Curr Opin Allergy Clin Immunol. 2018;18(1):51-8.

126. Brand PL, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriguez JA, Custovic A, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J. 2008;32(4):1096-110.

127. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162:1403-6.

128. Guilbert TW, Morgan WJ, Zeiger RS, Bacharier LB, Boehmer SJ, Krawiec M, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol. 2004;114(6):1282-7.

129. Wang F, He XY, Baines KJ, Gunawardhana LP, Simpson JL, Li F, et al. Different inflammatory phenotypes in adults and children with acute asthma. Eur Respir J. 2011;38(3):567-74.

130. Baines KJ, Simpson JL, Wood LG, Scott RJ, Fibbens NL, Powell H, et al. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. J Allergy Clin Immunol. 2014;133(4):997-1007.

131. Park HW, Dahlin A, Tse S, Duan QL, Schuemann B, Martinez FD, et al. Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids. J Allergy Clin Immunol. 2014;133(3):664-9.

132. Davidson EJ, Yang IV. Role of epigenetics in the development of childhood asthma. Curr Opin Allergy Clin Immunol. 2018 Jan 31. doi: 10.1097/ACI.0000000000000429.

133. Brand PL, Caudri D, Eber E, Gaillard EA, Garcia-Marcos L, Hedlin G, et al. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J. 2014;43(4):1172-7.

134. Just J, Saint-Pierre P, Gouvis-Echraghi R, Boutin B, Panayotopoulos V, Chebahi N, et al. Wheeze phenotypes in young children have different courses during the preschool period. Ann Allergy Asthma Immunol. 2013;111(4):256-61.

135. Schultz A, Brand PL. Episodic viral wheeze and multiple trigger wheeze in preschool children: a useful distinction for clinicians? Paediatr Respir Rev. 2011;12(3):160-4.

136. van Wonderen KE, Geskus RB, van Aalderen WM, Mohrs J, Bindels PJ, van der Mark LB, et al. Stability and predictiveness of multiple trigger and episodic viral wheeze in preschoolers. Clin Exp Allergy. 2016;46(6):837-47.

137. Schultz A, Devadason SG, Savenije OEM, Sly PD, Le Souf PN, Brand PLP. The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze. Acta Paediatr Int J Paediatr. 2010;99(1):56-60.

138. Just J, Saint-Pierre P, Amat F, Gouvis-Echraghi R, LambertGuillemot N, Guiddir T, et al. What lessons can be learned about asthma phenotypes in children from cohort studies? Pediatr Allergy Immunol. 2015;26(4):300-5.

139. Spycher BD, Cochrane C, Granell R, Sterne JAC, Silverman M, Pedersen E, et al. Temporal stability of multitrigger and episodic viral wheeze in early childhood. Eur Respir J. 2017;50(5). doi:

10.1183/13993003.00014-2017.

140. Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze. Lancet. 2014;383:1593‑604.

141. Cane RS, Ranganathan SC, McKenzie SA. What do parents of wheezy children understand by “wheeze?” Arch Dis Child. 2000;82:327‑32.

142. Espindola Filho M, Cavalcanti E, Silva Junior W, Bezerra P, Melo E, Britto M. Accuracy of wheezing in infants and preschool children by written questionnaire. In: 16th International Congress on Pediatric Pulmonology. Lisbon; 2017.

143. Lustosa G, Britto M, Bezerra P. Manejo de crises asmáticas em crianças: conhecimento de profissionais de saúde quanto ao tópico em hospitais-escola do Recife (PE). J Bras Pneumol. 2011;37:584‑8.

144. Castro-Rodriguez JA. The Asthma Predictive Index: a very useful tool for predicting asthma in young children. J Allergy Clin Immunol. 2010;126(2):212-6.

145. Bousquet J, Gern JE, Martinez FD, Anto JM, Johnson CC, Holt PG, et al. Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop. J Allergy Clin immunol. 2004;133(6):1535-46.

146. Devulapalli CS, Carlsen KC, Håland G, Munthe-Kaas MC, Pettersen M, Mowinckel P, et al. Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax. 2008;63(1):8-13.

147. Brand PL, Caudri D, Eber E, Gaillard EA, Garcia-Marcos L, Hedlin G, et al. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J. 2014;43(4):1172-7.

148. Sherriff A, Peters TJ, Henderson J, Strachan D; ALSPAC Study Team. Avon Longitudinal Study of Parents and Children. Risk factor associations with wheezing patterns in children followed longitudinally from birth to 3(1/2) years. Int J Epidemiol. 2001;30(6):1473-84.

149. Brunekreef B, Smit J, de Jongste J, Neijens H, Gerritsen J, Postma D, et al. The prevention and incidence of asthma and mite allergy (PIAMA) birth cohort study: design and first results. Pediatr Allergy Immunol. 2002;13(Suppl 15):55-60.

150. Pescatore AM, Dogaru CM, Duembgen L, Silverman M, Gaillard EA, Spycher BD, Kuehni CE. A simple asthma prediction tool for preschool children with wheeze or cough. J Allergy Clin Immunol. 2014;133:111-18.

151. Smit HA, Pinart M, Antó JM, Keil T, Bousquet J, Carlsen KH,Moons KGM, Hooft L, Lødrup Carlsen KC. Childhood asthma prediction models: a systematic review. Lancet Respir Med. 2015;3:973‑84.

152. Savenije OEM, Kerkhof M, Koppelman GH, Postma DS. Predicting who will have asthma at school age among preschool children. J Allergy Clin Immunol. 2012;130:325-31.

153. Johansson S. Milestones in understanding allergy and its diagnosis. Clin Exp All Rev. 2002;2:2-7.

154. Carr T, Saltoun C. Skin testing in allergy. Allergy Asthma Proc. 2012;33 (Suppl 1):S6-S8.

155. van der Valk J, Gerth van Wijk R, Hoorn E, Groenendijk L, Groenendijk IM, de Jong NW. Measurements and interpretation of skin prick test results. Clin Transl Allergy. 2016;23:6-8.

156. Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet P, Burney P, et al. Global Allergy and Asthma European Network. Allergic Rhinitis and its Impact on Asthma. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012;67:18-24.

157. Aranda C, Cocco, R, Pierotti F, Mallozi M, Porto A, Goudouris E, et al. Increased sensitization to several allergens over a 12-year period in Brazilian children. Pediatr Allergy Immunol. 2018;29(3):321-4.

158. Kerkhof M, Dubois A, Postma D, Schouten J, de Monchy J. Role and interpretation of total serum IgE measurements in the diagnosis of allergic airway disease in adults. Allergy. 2003;58:905-11.

159. Moneret-Vautrin D, Kanny G, Halpern G. Detection of antibody IgE by in vitro tests and diagnosis of food allergy. Allerg Immunol (Paris). 1993;25:198-204.

160. Hamilton R, Williams P. Specific IgE Testing Force of the American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma & Immunology. Human IgE antibody serology: a primer for the practicing North American allergist/immunologist. J Allergy Clin Immunol. 2010;126:33-8.

161. ThermoScientific ImmunoCAP Specific IgE. Disponível em:http://www.phadia.com/pt-BR/Produtos/Produtos/ImmunoCAPEnsaios/ImmunoCAP-Specific-IgE/. Acesso em: 18 de março de 2018.

162. Lopes de Oliveira L, Aderhold M, Brill M, Schulz G, RolinckWerninghaus C, Clare Mills E, et al. The value of specific IgE to peanuts and its component Ara h 2 in the diagnosis of peanut allergy. J Allergy Clin Immunol Pract. 2013;1:394-8.

163. Canonica G, Ansotegui I, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani C, et al. A WAO – ARIA – GA2LEN consensus document on molecular-based allergy diagnosis. World Allergy Organ J. 2013;6:1-17.

164. Ando H, Moverate R, Kondo Y, Tsuge I, Tanaka A, Borre M, et al. Utility of ovomucoid-specific IgE concentrations in predicting symptomatic egg allergy. J Allergy Clin Immunol. 2008;122:583-8.

165. Beydon N, Davis S, Lombardi E, Allen J, Arets J, Aurora P, et al. An official American Thoracic Society / European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007;175:1304-45.

166. Lanza F, Wandalsen G. Função pulmonar em lactentes. In: Solé D, Wandalsen G, Lanza F, eds. Asma no lactente, na criança e no adolescente. São Paulo: Ed. Atheneu; 2017. p. 49-60.

167. Sly P, Tepper R, Henschen M, Gappa M, Stocks J, ERS/ATS Task Force for Infant Respiratory Function Testing. Eur Respir J. 2000;16:741-8.

168. Gappa M, Colin A, Goetz I, Stocks J. Passive respiratory mechanics: the occlusion techniques. Eur Respir J. 2001;17:141-8.

169. Stocks J, Godfrey S, Beardsmore C, Bar-Yishay E, Castile R, ERS/ATS Task force on Standards for Infant Respiratory Function Testing. Plethysmographic measurements of lung volume and airway resistance. Eur Respir J. 2001;17:302-12.

170. American Thoracic Society/European Respiratory Society. Statement: raised volume forced expirations in infants. Am J Respir Crit Care Med. 2005;172:1463-71.

171. Rosenfeld M, Allen J, Arets B, Aurora P, Beydon N, Calogero C, et al. An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age. Ann Am Thoracic Soc. 2013;10:S1-S11.

172. Burity E, Pereira C, Rizzo J, Sarinho E, Jones M. Efeito da terminação precoce da expiração nos parâmetros espirométricos em crianças pré-escolares saudáveis. J Bras Pneumol. 2011;37:464-70.

173. França D, Camargos P, Jones M, Martins J, Vieira B, Colosimo E, et al. Prediction equations for spirometry in four- to six-year-old children. J Pediatr (Rio J). 2016;92:400-8.

174. Komarow H, Myles I, Uzzaman A, Metcalfe D. Impulse oscillometry in the evaluation of diseases of the airways in children. Ann Allergy Asthma Immunol. 2011;106:191-9.

175. Valle E. Resistência das vias aéreas: técnica da oscilação forçada. J Pneumol. 2002; 28(Supl 3):151-4.

176. Bickel S, Popler J, Lesnick B, Eid N. Impulse oscillometry. Chest. 2014;146:841-7.

177. Dos Santos K, Fausto LL, Camargos PAM, Kviecinski MR, da Silva J. Impulse oscillometry in the assessment of asthmatic children and adolescents: from a narrative to a systematic review. Paediatr Respir Rev. 2017;23:61-7.

178. Guilbert TW, Bacharier LB, Fitzpatrick AM. Severe asthma in children. J Allergy Clin Immunol Pract. 2014;2:489-500.

179. Finder J. Understanding Airway Disease in Infants. Curr Probl Pediatr. 1999;29:65-81.

180. Skytt N, Bønnelykke K, Bisgaard H. ‘‘To wheeze or not to wheeze’’: That is not the question. J Allergy Clin Immunol. 2012;130:403-7.

181. Weinberger M, Fischer A. Differential diagnosis of chronic cough in children. Allergy Asthma Proc. 2014;35:95-103.

182. National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma – summary report 2007. J Allergy Clin Immunol. 2007; 120(Suppl. 5):S94-S138.

183. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59‑99.

184. British Thoracic Society Scottish Intercollegiate Guidelines. British guideline on the management of asthma. Thorax. 2008;63(Suppl. 4):1-121.

185. Fuhlbrigge AL, Guilbert T, Spahn J, Peden D, Davis K. The influence of variation in type and pattern of symptoms on assessment in pediatric asthma. Pediatrics. 2006;118:619‑25.

186. Gustafsson PM, Watson L, Davis KJ, Rabe KF. Poor asthma control in children: evidence from epidemiological surveys and implications for clinical practice. Int J Clin Pract. 2006;60:321‑34.

187. Chipps BE, Zeiger RS, Borish L, Wenzel SE, Yegin A, Hayden ML, et al. Key findings and clinical implications from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. J Allergy Clin Immunol. 2012;130:332‑4.

188. Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics. 2001;108:E48.

189. Brodie M, Gupta A, Rodriguez-Martinez CE, Castro-Rodriguez JA, Ducharme FM, McKean MC. Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children. Cochrane Database Syst Rev. 2015: CD008202.

190. Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma. Disponível em https://clinicaltrials.gov/ct2/show/study/NCT01634113?sect=X156. Acessado em Janeiro de 2018.

191. McIvor ER, McIvor RA. The evolving role of tiotropium in asthma. J Asthma Allergy. 2017;10:231-6.

192. Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev.

2015 24;(11):CD007949.

193. Chipps BE, Bradley EC, Lanier B, Milgrom H, Deschildre A, Hedlin G, Szefler SJ, et al. Omalizumab in children with uncontrolled allergic asthma. Review of clinical trial and real-world experience. J Allergy Clin Immunol. 2017;139:1431-44.

194. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006;354:1998-2005.

195. Zeiger RS, Mauger D, Bacharier LB, Guilbert TW, Martinez FD, Lemanske RF Jr, et al. Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med. 2011;365:1990‑2001.

196. Loke YK, Blanco P, Thavarajah M, Wilson AM. Impact of inhaled corticosteroids on growth in children with asthma: systematic review and meta-analysis. PLoS One. 2015;10:e0133428.

197. Sanchis J, Corrigan C, Levy ML, Viejo JL, ADMIT Group. Inhaler devices-from theory to practice. Respir Med. 2013;107(4):495‑502.

198. Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, et al. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med. 2013;107:37‑46.

199. Dalby R, Spallek M, Voshaar T. A review of the development of Respimat Soft Mist Inhaler. Int J Pharm. 2004;283(1-2):1-9.

200. Heyder J, Gebhart F, Rudolf G, Schiller C F, Stahlhofen W. Deposition of particles in the human respiratory tract in the size range 0.005-15 μm. J Aerosol Sci. 1986;17:811-25.

201. Ariyananda PL, Agnew JE, Clarke SW. Aerosol delivery systems for bronchial asthma. Postgrad Med J. 1996;72(845):151-6.

202. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metereddose inhaler compared with CFC-beclomethasone. Eur Respir J. 1998;12(6):1346-53.

203. Lavorini F, Fontana GA. Targeting drugs to the airways: the role of spacer devices. Expert Op Drug Deliv. 2009;6:91‑102.

204. Piérart F, Wildhaber JH, Vrancken I, Devadason SG, Le Souëf PN. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J. 1999;13(3):673-8.

205. Taylor SA, Asmus MJ, Liang J, Coowanitwong I, Vafadari R, Hochhaus G. Performance of a corticosteroid inhaler with a spacer fashioned froma plastic cold-drink bottle: effects of changing bottle volume. J Asthma. 2003;40:237‑42.

206. Duarte M, Camargos P. Efficacy and safety of a homemade nonvalved spacer for bronchodilator therapy in acute asthma. Acta Paediatrica. 2002;91(9):909‑13.

207. Harari DK, Ferone EA, Kiertsman B. Dispositivos inalatórios. In: Solé D, Wandalsen GF, Lanza FC, eds. Asma no Lactente, na Criança e no Adolescente. São Paulo: Atheneu; 2017. p. 299‑311.

208. O’Callaghan C, Barry PW. The science of nebulised drug delivery. Thorax. 1997;52(2):S31-S44.

209. Szefler SJ, Murphy K, Harper III T, Boner A, Laki I, Engel M, et al. A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma. J Allergy Clin Immunol. 2017;140(5):1277‑87.

210. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/ American College of Asthma, Allergy, and Immunology. Chest. 2005;127(1):335‑71.

211. Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003(1):CD001117.

212. Mammen J, Rhee H. Adolescent asthma self-management: a concept analysis and operational definition. Pediatr Allergy Immunol Pulmonol. 2012;25(4):180-9.

213. Mammen J, Rhee H, Norton SA, Butz AM, Halterman JS, Arcoleo K. An integrated operational definition and conceptual model of asthma self-management in teens. J Asthma. 2018;19:1-13.

214. National Asthma Council Australia, disponível em https://www.nationalasthma.org.au/living-with-asthma/asthma-action-plans. Acesso em 31/01/2018.

215. British guideline on the management of asthma. A national clinical guideline. Sep 2016. Disponível em: https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthmaguideline-2016/ . Acesso em 04/02/2018.

216. Stevens CA, Wesseldine LJ, Couriel JM, Dyer AJ, Osman LM, Silverman M. Parental education and guided self-management of asthma and wheezing in the pre-school child: a randomised controlled trial. Thorax. 2002;57(1):39-44.

217. Hederos CA, Janson S, Hedlin G. Six-year follow-up of an intervention to improve the management of preschool children with asthma. Acta Paediatr. 2009;98(12):1939-44.

218. Szczepanski R, Jaeschke R, Spindler T, Ihorst G, Forster J, ASEV Study Group. Preschoolers’ and parents’ asthma education trial (P2AET): a randomized controlled study. Eur J Pediatr. 2010;169(9):1051-60.

219. Killian KJ, Watson R, Otis J, St Amand TA, O'Byrne PM. Symptom perception during acute bronchoconstriction. Am J Respir Crit Care Med. 2000;162:490-6.

220. Jansen J, McCaffery KJ, Hayen A, Ma D, Reddel HK. Impact of graphic format on perception of change in biological data: implications for health monitoring in conditions such as asthma. Prim Care Respir J. 2012;21:94-100.

221. Guevara JP, Wolf FM, Grum CM, Clark NM. Effects of educational interventions for self-management of asthma in children and adolescents: systematic review and meta-analysis. BMJ. 2003;326:1308-9.

222. Boyd M, Lasserson TJ, McKean MC, Gibson PG, Ducharme FM, Haby M. Interventions for educating children who are at risk of asthma-related emergency department attendance. Cochrane Database Syst Rev. 2009:CD001290.

223. Powell H, Gibson PG. Options for self-management education for adults with asthma. Cochrane Database Syst Rev. 2003:CD004107.

224. Gibson PG, Powell H. Written action plans for asthma: an evidencebased review of the key components. Thorax. 2004;59:94-9.

225. Asthma Buddy App. Disponível em https://www.asthmabuddy.org.au/#login. Acesso em 31/01/2018.

226. Asthma UK. Disponível em https://www.asthma.org.uk/advice/manage-your-asthma/. Acesso em 31/01/2018.

227. Asthma Society of Canada. Disponível em www.asthma.ca. Acesso em 31/01/2018.

228. Family Physician Airways Group of Canadá. Disponível em www.fpagc.com. Acesso em 31/01/2018.

229. World Allergy Organization. Pawankar R, Canonica GW, Holgate ST, Lockey RF. WAO White Book on Allergy 2011-2012: Executive Summary, USA, 2011. http://www.worldallergy.org/publications/wao_white_book.pdf . Acesso em janeiro de 2018

230. American Lung Association Epidemiology and Statistics Unit Research and Program Services Division. Trends in asthma morbidity and mortality. New York: American Lung Association, Setembro 2012. http://www.lung.org/assets/documents/research/asthma-trend-report.pdf. Acesso em janeiro de 2018.

231. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. International Study of asthma and allergies in childhood (ISAAC): rationale of methods. Eur Respir J. 1995;8:483-91.

232. Moonie S, Sterling DA, Figgs LW, Castro M. The relationship between school absence, academic performance, and asthma status. J Sch Health. 2008;78(3):140-8.

233. Akinbami L. Centers for Disease Control and Prevention National Center for Health Statistics. The state of childhood asthma. United States, 1980-2005. Adv Data. 2006;381:1‑24.

234. Urrutia-Pereira M, To T, Cruz AA, Solé D. The school as a health promoter for children with asthma: the purpose of an education programme. Allergol Immunopathol (Madr). 2017;45(1):93-8.

235. Muraro A, Clark A, Beyer K, Borrego LM, Borres M, Lodrup Carlsen KC, et al. The management of the allergic child at school: EAACI/ GA2LEN Task Force on the allergic child at school. Allergy. 2010;65(6):681-9.

236. Urrutia-Pereira M, Solé D. The allergic child at school. What do we need to know? Rev Alerg Mex. 2016;63(3):283-392.

237. Jaramillo Y, Reznik M. Do United States’ Teachers know and adhere to the National Guidelines on Asthma Management in the Classroom? A Systematic Review. Scientific World Journal. 2015;2015:624828.

238. Rubini NM, Wandalsen GF, Rizzo MCV, Aun MV, Chong Neto HJ, Solé D. Guia prático sobre controle ambiental para pacientes com rinite alérgica. Arq Asma Alerg Imunol. 2017;1(1):7-22.

239. Oeder S, Jorres RA, Weichenmeier I, Pusch G, Schober W, Pfab F, et al. Airborne indoor perticles from schools are more toxic than outdoor particles. Am J Respir Cell Mol Biol. 2012;47(5):575‑82.

240. United States Environmental Protection Agency, “IAQ tools for Schools,” Health and Achievement Managing Asthma in the School Environment. http://www.epa.gov/iaq/schools/managingasthma.html. Acesso em janeiro de 2018.

241. Inamdar AS, Croucher RE, Chokhandre MK, Mashyakhy MH, Marinho VC. Maternal Smokeless Tobacco Use in Pregnancy and Adverse Health Outcomes in Newborns: A Systematic Review. Nicotine Tob Res. 2015;17(9):1058-66.

242. Vardavas CI, Hohmann C, Patelarou E, Martinez D, Henderson AJ, Granell R, et al. The independ role of prenatal and postnatal exposure to active and passive smoking on the development of early wheeze in children. Eur Respir J. 2016;48(1):115-24.

243. Coleman BL, Fadel SA, Fitzpatrick T, Thomas SM. Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis. Influenza Other Resp Viruses. 2018;12(1):22-9.

244. Klopp A, Vehling L, Becker AB, Subbarao P, Mandhane PJ, Turvey SE, et al. Modes of Infant Feeding and the Risk of Childhood Asthma: A prospective Birth Cohort Study. J Pediatr. 2017;190:192‑199.e2.

245. Cano-Garcinuño A, Díaz-Vázquez C, Carvajal-Urueña I, PraenaCrespo M, Gatti-Viñoly A, García-Guerra I. Group education on asthma for children and caregivers: a randomized, controlled trial addressing effects on morbidity and quality of life. J Investig Allergol Clin Immunol. 2007;17(4):216-26.

246. Solé D, Urrutia-Pereira M, Sisul-Alvariza JC, Jares EJ, SánchezBorges M, Ansotegui IJ, et al. La Carta de Jerusalén: un nuevo paradigma en el cuidado de los niños y adolescentes alérgicos en las escuelas de Latinoamérica. Rev Alerg Mex. 2017;64(1):3-6.

247. Câmara Municipal do Rio de Janeiro. Lei nº 2852 de 28 de julho de 1999. Disponível em: https://cm-rio-de-janeiro.jusbrasil.com.br/legislacao/267266/lei-2852-99. Acesso em janeiro de 2018.

248. Cunha JCB. Uso de medicamentos na creche e na escola. In: Sociedade Brasileira de Pediatria. Tratado de Pediatria. Campos Júnior D, Burns DAR, orgs. 3ª ed. Barueri: Manole; 2014.

249. Presidência da República. Lei nº 12.546 de 14 de dezembro de 2011. Disponível em: http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2011/lei/l12546.htm. Acesso em janeiro de 2018.

250. Presidência da República. Decreto nº 8.262, de 31 de maio de 2014. Disponível em: http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2014/decreto/d8262.htm. Acesso em janeiro de 2018.

251. Swern AS, Tozzi CA, Knorr B, Bisgaard H. Predicting an asthma exacerbation in children 2 to 5 years of age. Ann Allergy Asthma Immunol. 2008;101:626-30.

252. National Heart Lung and Blood Institute N. Global initiative for asthma. Global strategy for asthma management and prevention. NHBLI/WHO workshop. 1995:NIH Publication no. 95-3659.

253. Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006;174:605‑14.

254. Miller EK, Avila PC, Khan YW, Word CT, Pelz BJ, Papadopoulos NG, et AL. Wheezing exacerbations in early childhood: evaluation, treatment, and recent advances relevant to the genesis of asthma. J Allergy Clin Immunol Pract. 2014;2(5):537‑43.

255. Just J, Nicoloyanis N, Chauvin M, Pribil C, Grimfeld A, Duru G. Lack of eosinophilia can predict remission in wheezy infants? Clin Exper Allergy. 2008;38:767‑73.

256. Guilbert TW, Morgan WJ, Krawiec M, Lemanske RF, Sorkness C, Szefler SJ, et al. The prevention of early asthma in kids study: design, rationale and methods for the childhood asthma research and education network. Cont Clin Trials. 2004;25:286‑310.

257. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Eng J Med. 2006;354:1985‑97.

258. Expert pannel report 3: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health: National Heart, Lung, and Blood Institute; 2007. Program NAEaP.

259. Center of Diseases Control. Rapid Influenza Diagnostic Tests. Disponível em: http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm. Acesso em 02/02/2018.

260. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal Influenza in Adults and Children-Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003‑32.

261. Navaie-Waliser M, Misener M, Mersman C, Lincoln P. Evaluating the Needs of Children With Asthma in Home Care: The Vital Role of Nurses as Caregivers and Educators. Public Health Nurs. 2004;21(4):306-15.

262. Chatkin JM; Machado, ARJ. Infecção respiratória aguda na criança. In: Duncan BD, Schmidt MI, Giugliani ERJ. Medicina ambulatorial: condutas de atenção primária baseadas em evidências. 3a ed. Porto Alegre: Artmed; 2004. p. 1335-41.

263. Geelhoed GC, Landau LI, Le Souef PN. Evaluation of SaO2 as a predictor of outcome in 280 children presenting with acute asthma. Ann Emerg Med. 1994;23:1236-41.

264. Gouin S, Robidas I, Gravel J, Guimont C, Chalut D, Amre D. Prospective evaluation of two clinical scores for acute asthma in children 18 months to 7 years of age. Acad Emerg Med. 2010;17:598-603.

265. Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X, et al. The Pediatric Respiratory Assessment measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers: J. Pediatr. 2008;152:476-80.

266. Ducharme FM, Zemek RL, Chalut D, McGillivray D, Nova FJ, Resendes S, et al. Written action plan in pediatric emergency room improves asthma rescribing, adherence, and control. Am J Respir Crit Care Med. 2011;183(2):195‑203.

267. Smith SR, Jaffe DM, Fisher EB, Trinkaus KM, Highstein G, Strunk RC. Improving follow-up for children with asthma after an acute Emergency Department visit. J Pediatr. 2004;145:772‑7.

268. Mitselou N, Hedlin G, Hederos CA. Spacers versus nebulizers in treatment of acute asthma – a prospective randomized study in preschool children. J Asthma. 2016;53(10):1059‑62.

269. Ribeiro JD, de Britto MCA. Sibilancia Recorrente do Lactente e Pré-escolar. In: de Matos Bezerra PG, de Brito R de CCM, de Britto MCA, eds. Pneumologia Pediátrica. 1ª ed. Rio de Janeiro: Medbook; 2016. p. 167‑78.

270. Sociedade Brasileira de Pediatria (SBP). Diretrizes para o manejo da infecção causada pelo vírus sincicial respiratório (VSR) - 2017. Disponível em http://www.sbp.com.br/fileadmin/user_upload/20277e-Diretrizes_VSR.pdf. Acesso em janeiro de 2018.

271. Pollock M, Sinha IP, Hartling L, Rowe BH, Schreiber S, Fernandes RM. Inhaled short-acting bronchodilators for managing emergency childhood asthma: an overview of reviews. Allergy Eur J Allergy Clin Immunol. 2017;72(2):183-200.

272. Saito M, Kikuchi Y, Lefor AK, Hoshina M. High-dose nebulized budesonide is effective for mild asthma exacerbations in children under 3 years of age. Eur Ann Allergy Clin Immunol. 2017;49(1):22-7.

273. Yanagida N, Tomikawa M, Shukuya A, Iguchi M, Ebisawa M. Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks. World Allergy Organ J. 2015;8(1):1-7.

274. Razi CH, Cörüt N, Andıran N. Budesonide reduces hospital admission rates in preschool children with acute wheezing. Pediatr Pulmonol. 2017;52(6):720‑8.

275. Papi A, Nicolini G, Boner AL, Baraldi E, Cutrera R, Fabbri LM, et al. Short term efficacy of nebulized beclomethasone in mild-tomoderate wheezing episodes in pre-school children. Ital J Pediatr. 2011;37(1):1-6.

276. Castro-Rodríguez JA, Beckhaus AA, Forno E. Efficacy of oral corticosteroids in the treatment of acute wheezing episodes in asthmatic preschoolers: systematic review with meta-analysis. Pediatr Pulmonol. 2016;51(8):868-76.

277. Mandhane PJ, Paredes Zambrano de Silbernagel P, Aung YN, Williamson J, Lee BE, Spier S, et al. Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: a placebo-controlled randomized trial. PLoS One. 2017:1-15.

278. Bush A, Grigg J, Saglani S. Managing wheeze in preschool children. BMJ. 2014;348:1-7.

279. Nieto A, Wahn U, Bufe A, Eigenmann P, Halken S, Hedlin G, et al. Allergy and asthma prevention 2014. Pediatr Allergy Immunol. 2014;25(6):516-33.

280. Bousquet J, Grattan C, Bieber T, Matricardi P, Simon HU, Wahn U, et al. Prediction and prevention of allergy and asthma in EAACI journals (2016). Clin Transl Allergy. 2017;7:46.

281. Van Odjik J, Kull I, Borres MP, Brandtzaeg P, Edberg U, Hanson LA, et al. Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations. Allergy. 2003;58:833-43.

282. Elbert NJ, van Meel ER, den Dekker HT, de Jong NW, Nijsten TEC, Jaddoe VWV, et al. Duration and exclusiveness of breastfeeding and risk of childhood atopic diseases. Allergy. 2017;72:1936‑43.

283. Bion V, Lockett GA, Soto-Ramirez N, Zhang H, Venter C, Karmaus W, et al. Evaluating the efficacy of breastfeeding guidelines on longterm outcomes for allergic disease. Allergy. 2016;71:661‑70.

284. Elliott L, Henderson J, Northstone K, Chiu GY, Dunson D, London SJ. Prospective study of breast-feeding in relation to wheeze, atopy, and bronchial hyperresponsiveness in the Avon Longitudinal Study of Parents and Children (ALSPAC). J Allergy Clin Immunol. 2008;122:49-54.

285. Mandhane PJ, Greene JM, Sears MR. Interactions between breastfeeding, specific parental atopy, and sex on development of asthma and atopy. J Allergy Clin Immunol. 2007;119:1359-66.

286. Lodge CJ, Tan DJ, Lau MX, Dai X, Tham R, Lowe AJ, et al. Breastfeeding and asthma and allergies: a systematic review and meta-analysis. Acta Paediatr. 2015;104:38-53.

287. Sonnenschein-van der Voort AM, Jaddoe VW, van der Valk RJ, Willemsen SP, Hofman A, Moll HA, et al. Duration and exclusiveness of breastfeeding and childhood asthma-related symptoms. Eur Respir J. 2012;39:81‑9.

288. den Dekker HT, Sonnenschein-van der Voort AM, Jaddoe VW, Reiss IK, de Jongste JC, Duijts L. Breastfeeding and asthma outcomes at the age of 6 years: the generation R study. Pediatr Allergy Immunol. 2016;27:486-92.

289. Dogaru CM, Nyffenegger D, Pescatore AM, Spycher BD, Kuehni CE. Breastfeeding and childhood asthma: systematic review and meta-analysis. Am J Epidemiol. 2014;179:1153‑67.

290. Cuello-Garcia CA, Fiocchi A, Pawankar R, Yepes-Nuñez JJ, Morgano GP, Zhang Y et al. Prebiotics for the prevention of allergies: A systematic review and meta-analysis of randomized controlled trials. Clin Exp Allergy. 2017;47:1468‑77.

291. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet. 2001;357:1076-79.

292. Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:1019-21.

293. Zuccotti G, Meneghin F, Aceti A, Barone G, Callegari ML, Di Mauro A, et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy. 2015;70:1356-71.

294. Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy. 2007;37:498-505.

295. Edwards MR, Walton RP, Jackson DJ, Feleszko W, Skevaki C, Jartti T, et al. The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations. Allergy. 2018;73(1):50-63.

296. Turturice BA, McGee HS, Oliver B, Baraket M, Nguyen BT, Ascoli C, et al. Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction. PLoS ONE. 2017;12(10): e0184566.

297. Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E. Probiotic administration in early life, atopy, and asthma: a metaanalysis of clinical trials. Pediatrics. 2013;132:666-76.

298. Zhang GQ, Hu HJ, Liu CY, Zhang Q, Shakya S, Li ZY. Probiotics for Prevention of Atopy and Food Hypersensitivity in Early Childhood: A PRISMA-Compliant Systematic Review and MetaAnalysis of Randomized Controlled Trials. Medicine (Baltimore). 2016;95:e2562.

299. Cuello-Garcia CA, Brozek JL, Fiocchi A, Pawankar R, Yepes-Nunez JJ, Terracciano L, et al. Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2015;136:952-61.

300. Azad MB, Coneys JG, Kozyrskyj AL, Field CJ, Ramsey CD, Becker AB, et al. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ. 2013;347:6471.

301. Fiocchi A, Pawankar R, Cuello-Garcia C, Ahn K, Al-Hammadi S, Agarwal A, et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics. World Allergy Org J. 2015;8:4.

302. Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database of Systematic Reviews. 2015; Issue 2. Art. No.: CD006895.

303. Barreto BA. Microbioma and probiotics: from gut to Mars. Braz J Otorhinolaryngol. 2017. http:// dx.doi.org/10.1016/j.bjorl.2017.10.004.

304. de Araujo GV, Peixoto DM, Sarinho ESC, de Lorena VMB, Montenegro SM, de Albuquerque EC. Probiotics as an adjunct for the treatment of recurrent wheezing in infants and effects on expression of T-helper 1 and regulatory T cytokines. J Funct Foods. 2017;35:398-407.

305. Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, Puntis JW, et al. Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2004;39:465‑73.

306. Osborn DA, Sinn JK. Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev. 2013;3:CD006474.

307. Mennini M, Dahdah L, Artesani MC, Fiocchi A, Martelli A. Probiotics in Asthma and Allergy Prevention. Front Pediatr. 2017;5:165

308. Zuccotti G, Meneghin F, Aceti A, Barone G, Callegari ML, DiMauro A, et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy. 2015;70:1356-71.

309. Halken S, Larenas-Linnemann D, Roberts G, Calderón MA, Angier E, Pfaar O, et al. EAACI guidelines on allergen immunotherapy: Prevention of allergy. Pediatr Allergy Immunol. 2017;28(8):728‑45.

310. Dinakar C, Portnoy JM. Allergen immunotherapy in the prevention of asthma. Curr Opin Allergy Clin Immunol. 2004;4(2):131-6.

311. Bozek A, Jarzab J, Bednarski P. The effect of allergenspecific immunotherapy on offspring. Allergy Asthma Proc. 2016;37:59‑63.

312. Oykhman P, Kim HL, Ellis AK. Allergen immunotherapy in pregnancy. Allergy Asthma Clin Immunol. 2015;11:31.

313. Flicker S, Marth K, Kofler H, Valenta R. Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapytreated mother. J Allergy Clin Immunol. 2009;124:1358‑60.

314. Glovsky MM, Ghekiere L, Rejzek E. Effect of maternal immunotherapy on immediate skin test reactivity, specific rye I IgG and IgE antibody, and total IgE of the children. Ann Allergy. 1991;67:21‑4.

315. Settipane RA, Chafee FH, Settipane GA. Pollen immunotherapy during pregnancy: long-term follow-up of offsprings. Allergy Proc. 1988;9:555‑61.